<DOC>
	<DOC>NCT00796367</DOC>
	<brief_summary>The purpose of this study is to evaluate the long-term safety and efficacy of VI-0521 compared to placebo for the treatment of overweight and obesity in adults who have completed study OB-303 (NCT00553787) at selected study sites. This is an extension study of protocol OB-303 (NCT00553787).</brief_summary>
	<brief_title>A Safety and Efficacy Study of VI-0521 to Evaluate the Long Term Treatment of Obesity in Adults With Obesity-Related Co-Morbid Conditions. An Extension Study of Protocol OB-303 (NCT00553787)</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<mesh_term>Phentermine</mesh_term>
	<criteria>To be eligible for enrollment into this study, subjects must meet all of the following criteria: Completion of study OB303 (NCT00553787) on treatment and compliance with all protocol requirements Written informed consent Female subjects of childbearing potential must be using adequate contraception, defined as doublebarrier methods, stable hormonal contraception plus single barrier method, or tubal ligation. Female subjects are considered to be of childbearing potential unless they have undergone a hysterectomy or bilateral oophorectomy, are ≥55 years of age and experienced spontaneous cessation of menses for at least 1 year, or have a documented folliclestimulating hormone level ≥40 IU/L Willingness and ability to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures. Subjects will not be included in the study if they meet any of the following: Body mass index ≤22 kg/m2 at the completion of study OB303 Off study medication at completion of study OB303 (NCT00553787) for longer than 4 weeks continuously due to an eventdriven holiday, or off study medication with no plans to restart Development of any condition during study OB303 (NCT00553787) that, in the opinion of the investigator, would contraindicate the administration of study medication, affect compliance, interfere with study evaluations, or confound the interpretation of study results Participation in a formal weight loss program (including: Weight Watchers and related dietary/lifestyle intervention programs; prepared food programs; prescribed or over the counter weight loss medications; dietary supplement or herbal preparations, teas, or tinctures intended for weight loss; or any supervised fast or very low calorie diet).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Obesity</keyword>
</DOC>